BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Heart, Autoimmunity, Bleomycin, rs2230926, SIRT1, T cell receptor signaling pathway)
Bookmark Forward

QuickView for VHL (gene)


Body Atlas

Most Correlated Tissues

  1. Fetal brain
  2. Bone marrow
  3. Lymph nodes
  4. Cerebellar vermis
  5. Vulva
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Neurocutaneous syndrome
  2. Erythrocytosis
  3. Viremia
  4. Disease due to Enterovirus
  5. Hemorrhagic shock
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. stau2 protein, mouse
  2. GW0742
  3. Tween 80
  4. JM 3100
  5. Cholesterol
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. Gata4
  2. FAM110B
  3. SETX
  4. STAU1
  5. MUTYH
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Effects of Germline VHL Deficiency on Growth, Metabolism, and Mitochondria.
  2. Squalene deters drivers of RCC disease progression beyond VHL status.
  3. MiR-340 Promotes the Proliferation of Vascular Smooth Muscle Cells by Targeting von Hippel-Lindau Tu…
  4. Rapid and direct control of target protein levels with VHL-recruiting dTAG molecules.
  5. The Daam2-VHL-Nedd4 axis governs developmental and regenerative oligodendrocyte differentiation.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesion…
  2. Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumor…
  3. TKI 258 in Von Hippel-Lindau Syndrome (VHL)
  4. Assessment of Residual VHL Function in Tumors - Can it Predict the Patients' Individual Course of Di…
  5. Study of Sunitinib in Patients With Von Hippel-Lindau (VHL) Disease
Explore Clinical Trials Results
  • Copyright © 2022 Illumina Inc. All rights reserved.